ArticleACR open rheumatology2020

Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.